196 related articles for article (PubMed ID: 31671001)
1. Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups.
Soares E; Pereira FC
Expert Opin Pharmacother; 2019 Dec; 20(18):2273-2293. PubMed ID: 31671001
[No Abstract] [Full Text] [Related]
2. Pharmacological treatments for methamphetamine addiction: current status and future directions.
Ballester J; Valentine G; Sofuoglu M
Expert Rev Clin Pharmacol; 2017 Mar; 10(3):305-314. PubMed ID: 27927042
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Kishi T; Matsuda Y; Iwata N; Correll CU
J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
[TBL] [Abstract][Full Text] [Related]
5. The neurobiological mechanisms of physical exercise in methamphetamine addiction.
Morais APD; Pita IR; Fontes-Ribeiro CA; Pereira FC
CNS Neurosci Ther; 2018 Feb; 24(2):85-97. PubMed ID: 29266758
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
Siefried KJ; Acheson LS; Lintzeris N; Ezard N
CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
[TBL] [Abstract][Full Text] [Related]
7. Effects of a methamphetamine vaccine, IXT-v100, on methamphetamine-related behaviors.
Keller CM; Spence AL; Stevens MW; Owens SM; Guerin GF; Goeders NE
Psychopharmacology (Berl); 2020 Mar; 237(3):655-667. PubMed ID: 31758209
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder.
Aryan N; Banafshe HR; Farnia V; Shakeri J; Alikhani M; Rahimi H; Sehat M; Mamsharifi P; Ghaderi A; Omidi A
Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):72. PubMed ID: 32977820
[TBL] [Abstract][Full Text] [Related]
9. Treatments for methamphetamine abuse: a literature review for the clinician.
Brackins T; Brahm NC; Kissack JC
J Pharm Pract; 2011 Dec; 24(6):541-50. PubMed ID: 22095579
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of amphetamine-type stimulant dependence: an update.
Brensilver M; Heinzerling KG; Shoptaw S
Drug Alcohol Rev; 2013 Sep; 32(5):449-60. PubMed ID: 23617468
[TBL] [Abstract][Full Text] [Related]
11. Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder.
Li MJ; Briones MS; Heinzerling KG; Kalmin MM; Shoptaw SJ
Drug Alcohol Depend; 2020 Jan; 206():107776. PubMed ID: 31812878
[TBL] [Abstract][Full Text] [Related]
12. Current and Emerging Treatments for Methamphetamine Use Disorder.
Moszczynska A
Curr Neuropharmacol; 2021; 19(12):2077-2091. PubMed ID: 34344291
[TBL] [Abstract][Full Text] [Related]
13. Effect of the environmental enrichment on the severity of psychological dependence and voluntary methamphetamine consumption in methamphetamine withdrawn rats.
Hajheidari S; Miladi-Gorji H; Bigdeli I
Neurosci Lett; 2015 Jan; 584():151-5. PubMed ID: 25459292
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis.
Bhatt M; Zielinski L; Baker-Beal L; Bhatnagar N; Mouravska N; Laplante P; Worster A; Thabane L; Samaan Z
Syst Rev; 2016 Nov; 5(1):189. PubMed ID: 27842569
[TBL] [Abstract][Full Text] [Related]
15. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
Pérez-Mañá C; Castells X; Torrens M; Capellà D; Farre M
Cochrane Database Syst Rev; 2013 Sep; (9):CD009695. PubMed ID: 23996457
[TBL] [Abstract][Full Text] [Related]
17. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
Miles SW; Sheridan J; Russell B; Kydd R; Wheeler A; Walters C; Gamble G; Hardley P; Jensen M; Kuoppasalmi K; Tuomola P; Föhr J; Kuikanmäki O; Vorma H; Salokangas R; Mikkonen A; Kallio M; Kauhanen J; Kiviniemi V; Tiihonen J
Addiction; 2013 Jul; 108(7):1279-86. PubMed ID: 23297867
[TBL] [Abstract][Full Text] [Related]
18. A qualitative study of methamphetamine initiation among Chinese male users: Patterns and policy implications.
Liu L; Chui WH; Chai X
Int J Drug Policy; 2018 Dec; 62():37-42. PubMed ID: 30359871
[TBL] [Abstract][Full Text] [Related]
19. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
[TBL] [Abstract][Full Text] [Related]
20. Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder.
Heinzerling KG; Briones M; Thames AD; Hinkin CH; Zhu T; Wu YN; Shoptaw SJ
J Neuroimmune Pharmacol; 2020 Jun; 15(2):238-248. PubMed ID: 31820289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
